Product Information
OXYBUTYNIN 5 MG TABLET is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.0473 per EA under NDC 64980043101. Its NADAC has been published 407 times since Apr 4, 2018.
The High Outlier badge above means this manufacturer's average price in the OXYBUTYNIN CHLORIDE market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
5 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
64980043101
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
OXYBUTYNIN CHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA209025On Market Since
2/1/2018
Pharmacological Classes
Price Statistics
The NADAC for OXYBUTYNIN 5 MG TABLET has been published 407 times since Apr 4, 2018, and over the history we have for it it has declined 80.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0473 per EA |
|---|---|
| All-time high | $0.2477 (Apr 11, 2018) |
| All-time low | $0.0448 (Nov 20, 2024) |
| 52-week high | $0.0505 |
| 52-week low | $0.0455 |
| Median price | $0.0745 |
| Average price | $0.0941 |
| Largest weekly change | -28.1% (Apr 17, 2024) |
| Weeks tracked | 407 |
| Tracking since | Apr 4, 2018 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of OXYBUTYNIN 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for OXYBUTYNIN 5 MG TABLET, manufactured by Rising Pharma Holdings Inc., is $0.0473 per EA (NDC 64980043101), effective Jun 24, 2026.
How has the price of OXYBUTYNIN 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for OXYBUTYNIN 5 MG TABLET has declined 80.9%. It has been tracked across 407 weekly CMS publications since Apr 4, 2018.
What are the highest and lowest recorded NADAC prices for OXYBUTYNIN 5 MG TABLET?
Since Apr 4, 2018, the NADAC for OXYBUTYNIN 5 MG TABLET has ranged from a low of $0.0448 (Nov 20, 2024) to a high of $0.2477 (Apr 11, 2018), with a median of $0.0745 per EA.
Are there cheaper alternatives to OXYBUTYNIN 5 MG TABLET?
3 NADAC-published products share the same active ingredient, strength, and dosage form as OXYBUTYNIN 5 MG TABLET, but none are currently priced below it.
Who manufactures OXYBUTYNIN 5 MG TABLET?
OXYBUTYNIN 5 MG TABLET (NDC 64980043101) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification